Emami Limited · NSE:EMAMILTD

Emami — Q2 FY2020 Earnings Presentation

16 slides from Emami's earnings presentation, Nov 6, 2019

  1. Slide 1: Exchange filing cover letter

    cmamT limited emarru* Date: 6th November, 2019 The Secretary The Secretary The National Stock Exchange of India Ltd. BSELimited Exchange Plaza, Plot No. C/1, G. Block Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai - 400 051 Mumbai - 400 001 The Secretary The Calcutta

  2. Slide 2: Q2 & H1FY20 Performance Update

    Q2 & H1FY20 Performance Update 6th November 2019

  3. Slide 3: Performance Snapshot (Consolidated)

    Performance Snapshot (Consolidated) ₹ in Millions Revenue from Operations EBIDTA PAT Q2FY20 6,601 Q2FY20 1,930 Q2FY20 960 Q2FY19 6,282 Q2FY19 1,873 Q2FY19 827 Revenue from Operations EBIDTA PAT H1FY20 H1FY20 3,280 H1FY20 1,353 13,096 H1FY19 12,432 H1FY19 3,084 H1FY19 1,093 1

  4. Slide 4: Business Performance

    Business Performance BUSINESS WISE NET SALES PERFORMANCE H1FY20 Business Wise Sales Split Q2FY20 H1FY20 Domestic CSD (incl. CSD) 4% 3% IMD 15% 2% International Business Domestic 20% 81% 25%  Consolidated Volume growth of 2.9% in Q2FY20 • Domestic Volume growth of 1.0% including CSD Channel • CSD Ch

  5. Slide 5: BoroPlus Pain Management

    BoroPlus  BoroPlus range grew by 39% during the quarter and by 29% in H1FY20  Rechristened the brand as – “BoroPlus Ayurvedic Antiseptic Cream” to highlight the ‘natural’ ingredients.  BoroPlus Ayurvedic Antiseptic cream Market Share (vol) at 75.2% increased by 200 bps in Q2FY20 Pain Management 

  6. Slide 6: Kesh King 7 Oils in One

    Kesh King  Kesh King range declined by 11% during the quarter due to slowdown in discretionary consumption. Sales, however grew by 8% in H1FY20.  Q2FY20 Market Share (vol) at 26.6% grew by 140 bps 7 Oils in One  7 Oils in One grew by 25% during the quarter and by 28% in H1FY20  Roped in Katrina

  7. Slide 7: Navratna Healthcare range

    Navratna  Navratna range declined by 3% during the quarter. However, it grew by 2% in H1FY20  Maintained leadership with a Market Share (vol) at 65.5% in Q2FY20 Healthcare range  Healthcare range posted flat growth during the quarter. However, it declined by 2% in H1FY20 • Ex-Pancharishta, Health

  8. Slide 8: Male Grooming

    Male Grooming  Macroeconomic factors impacting discretionary consumption adversely.  Male grooming range declined by 32% during the quarter and by 19% in H1FY20.  Male Fairness cream category grew by 2.5% in volumes, while Fair and Handsome Cream grew by 4.6% in Q2FY20 as per AC Nielsen.  Fairne

  9. Slide 9: International Business

    International Business  Sales grew by 20% during the quarter and by 25% in H1FY20 OTHERS 4%  Excluding Creme 21, sales grew by 7% during the AFRICA 6% quarter and by 8% in H1FY20 CIS 9%  SAARC and MENAP grew strongly IMD H1FY20 SAARC Cluster Wise 43% Contribution  Market Shares gains continued a

  10. Slide 10: Q2FY20 Financial analysis

    Q2FY20 Financial analysis Cost of Goods Sold Staff Costs A&P Spends (as a % of Sales) (as a % of Sales) (₹ in Millions) - 110 bps +10 bps 31.4% 11.4% 11.4% 1,049 30.3% 995 Q2FY19 Q2FY20 Q2FY19 Q2FY20 Q2FY19 Q2FY20 Admin & Other Exp Other Income Interest Paid (as a % of Sales) (₹ in Millions) (₹ in M

  11. Slide 11: H1FY20 Financial analysis

    H1FY20 Financial analysis Cost of Goods Sold Staff Costs A&P Spends (as a % of Sales) (as a % of Sales) (₹ in Millions) + 50 bps + 30 bps -160 bps 33.0% 11.7% 2,421 2,340 32.5% 11.4% H1FY19 H1FY20 H1FY19 H1FY20 H1FY19 H1FY20 Admin & Other Exp Other Income Interest Paid (as a % of Sales) (₹ in Millio

  12. Slide 12: Q2FY20 Summarized Financials

    Q2FY20 Summarized Financials ₹ in Millions Particulars Q2FY20 % Q2FY19 % Growth % FY19 % Net Sales 6,491.7 98.4% 6,183.4 98.4% 5.0% 26,589.2 98.7% Other Operating Income 108.8 1.6% 98.7 1.6% 10.2% 357.1 1.3% Revenue from Operations 6,600.5 100.0% 6,282.1 100.0% 5.1% 26,946.3 100.0% Materials Cost 1,

  13. Slide 13: H1FY20 Summarized Financials

    H1FY20 Summarized Financials ₹ in Millions Particulars H1FY20 % H1FY19 % Growth % FY19 % Net Sales 12,876.9 98.3% 12,230.6 98.4% 5.3% 26,589.2 98.7% Other Operating Income 218.7 1.7% 201.3 1.6% 8.6% 357.1 1.3% Revenue from Operations 13,095.6 100.0% 12,431.9 100.0% 5.3% 26,946.3 100.0% Materials Cos

  14. Slide 14: Balance Sheet

    Balance Sheet ₹ in Millions Consolidated Consolidated S.N. ASSETS Unaudited Audited S.N. LIABILITIES Unaudited Audited As at 30.09.2019 As at 31.03.2019 As at 30.09.2019 As at 31.03.2019 1 Non -Current Assets Equity (a) Property, Plant and Equipment 7,740 7,490 (a) Equity Share capital 454 454 (b) C

  15. Slide 15: Awards & Accolades

    Awards & Accolades  Emami Group was conferred with “Star of the Year” at the 10th edition of Think CSR 2019 Award organized by Tefla’s.  Navrata won 4 prestigious awards for its campaigns –  Gold Award for ‘Kumbh Mein Sukun’ at Flame Awards Asia 2019 -Best Campaign for Leveraging Technology Exper

  16. Slide 16: Thank you

    Thank you

Emami — Q2 FY2020 Earnings Presentation on 6ix